DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the agenda for its Analyst and Investor Day webcast, to take place from 10 am to 12:15 pm GMT on Friday, December 14th in London, UK.
Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
| 10:00 (5 min.) | Welcome and Introductions | Timothy L. Enns |
| SVP, Corporate Communications and Marketing | ||
| 10:05 (10 min.) | Corporate Overview | James S.J. Manuso, PhD, MBA |
| Chairman and Chief Executive Officer | ||
| 10:15 (20 min.) | Clinical Update | Mohammad Azab, MD, M Sc, MBA |
| Chief Medical Officer | ||
| 10:35 (25 min.) | AT13387 & Prostate Cancer | Johann de Bono, MD, PhD |
| Royal Marsden Hospital | ||
| Institute of Cancer Research (ICR) | ||
| 11:00 (25 min.) | SGI-110 & Ovarian Cancer | Robert Brown, PhD |
| Imperial College London | ||
| Institute of Cancer Research (ICR) | ||
| 11:25 (20 min.) | Research & Discovery | Harren Jhoti, PhD |
| President and Director | ||
| 11:45 (15 min.) | Partnering & Corporate Development | Martin Buckland, DPhil, MBA |
| Chief Business Officer | ||
| 12:00 (10 min.) | Financial Overview | Michael Molkentin, CPA |
| Chief Financial Officer and Corporate Secretary | ||
| 12:10 (5 min.) | Closing Remarks | James S.J. Manuso, PhD, MBA |
| Chairman and Chief Executive Officer |
The times listed above are approximate and are subject to change.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273